DGAP-News: Hannover Re substantially increases Group net

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
DGAP-News: Hannover Re substantially increases Group net income

DGAP-News: Hannover Rück SE / Key word(s): 9-month figures Hannover Re substantially increases Group net income 05.11.2014 / 07:30 --------------------------------------------------------------------- Press release Hannover Re substantially increases Group net income - Group net income +10.3%: EUR 695.4 million (EUR 630.2 million) - Net major losses of EUR 242.2 million well below the expected level - Combined ratio in property and casualty reinsurance: 95.3% - Gross premium growth (currency-adjusted): +2.9% - Income from assets under own management +6.4%: EUR 836.0 million (EUR 785.6 million) - Return on investment: 3.3% - Book value per share: EUR 58.01 - Return on equity: 14.4% Hannover, 5 November 2014: Hannover Re is very satisfied with the development of its business as at 30 September 2014. Despite difficult general conditions, Group net income was boosted by 10.3% relative to the previous year's period to EUR 695.4 million. "Both business groups and the investment income fully lived up to our expectations", Chief Executive Officer Ulrich Wallin affirmed. "We are well placed to navigate the challenging market environment and are confident of achieving our full-year profit target in the order of EUR 850 million." Currency-adjusted gross premium slightly higher The gross written premium booked by the Hannover Re Group for the first nine months increased by 1.6% to EUR 10.7 billion (EUR 10.5 billion). At constant exchange rates growth would have come in at 2.9%. The company is thus within its target corridor of generating stable to slightly higher gross premium for the full financial year. The retention retreated to 87.0% (88.9%). Net premium earned consequently fell by a modest 1.7% to EUR 9.0 billion (EUR 9.1 billion); adjusted for exchange rate effects, the decrease would have been 0.5%. Good Group net income for the first nine months The operating profit (EBIT) as at 30 September 2014 rose by a pleasing 10.7% to EUR 1,090.8 million (EUR 985.8 million). Group net income also improved on the comparable period's already good figure by a further 10.3% to reach EUR 695.4 million (EUR 630.2 million). Earnings per share amounted to EUR 5.77 (EUR 5.23). Property and casualty reinsurance delivers another good result Property and casualty reinsurance continues to be intensely competitive. This was also evident in the treaty negotiations as at 1 July 2014, when parts of the North American portfolio, most agricultural risks and business from Latin America came up for renewal. Total gross premium for property and casualty reinsurance increased by 1.7% as at 30 September 2014 to EUR 6.1 billion (EUR 6.0 billion). At constant exchange rates a gain of 3.2% would have been booked. The growth generated by Hannover Re in spite of its disciplined underwriting policy can be attributed largely to attractive opportunities in emerging markets. The company's retention rose slightly to 89.6% (89.1%). Net premium earned was on the level of the previous year at EUR 5.1 billion (EUR 5.1 billion); adjusted for exchange rate effects, an increase of 1.5% would have been recorded. Following a low burden of major losses in the first half of 2014, major loss expenditure climbed slightly in the third quarter. The aviation line was particularly hit, with the largest single loss resulting from armed conflicts in Libya which left Tripoli airport heavily damaged. Hannover Re anticipates a net strain of EUR 50.0 million in this regard. The crash of the Malaysia Airlines plane over Ukraine caused a loss of EUR 32.2 million for net account. Total net expenditure on major loss events as at 30 September 2014 came to EUR 242.2 million (EUR 446.7 million); it was thus well below the company's expected level of EUR 491 million for the period. The underwriting result was again pleasing at EUR 225.3 million (EUR 243.4 million). The combined ratio of 95.3 % (95.0 %) came in better than the company's set target. The operating profit (EBIT) for property and casualty reinsurance as at 30 September 2014 closed at a very favourable EUR 846.8 million (EUR 804.6 million). Group net income climbed 5.0% to EUR 560.8 million (EUR 534.4 million). Earnings per share totalled EUR 4.65 (EUR 4.43). Life and health reinsurance shows stronger result Gross premium in life and health reinsurance increased by a modest 1.4% to EUR 4.6 billion (EUR 4.6 billion). This is equivalent to an increase of 2.6% after adjustment for exchange rate effects. The third quarter passed off particularly favourably. Hannover Re continues to see growth potential driven by rising prosperity, especially in emerging economies, and also worldwide on account of increasingly exacting regulatory requirements. In view of a reduced retention of 83.7% (88.5%), net premium earned retreated more sharply by 4.0% to EUR 3.9 billion (EUR 4.0 billion); adjusted for exchange rate effects, this corresponds to a reduction of 2.9%. The operating profit (EBIT) in life and health reinsurance rose by a substantial 39.6% as at 30 September 2014 to EUR 233.9 million (EUR 167.6 million). Losses such as those incurred in the previous year in the Australian disability portfolio and to some extent also in US mortality business played virtually no further role in the current reporting period. Group net income improved by 8.6% to EUR 166.2 million (EUR 153.0 million). The fact that the increase was not more marked can be attributed to exceptionally low tax expenditure in the previous year's comparable period. Earnings per share reached EUR 1.38 (EUR 1.27). Very positive investment income The portfolio of assets under own management grew by EUR 3.2 billion as at 30 September 2014 to EUR 35.0 billion. The increase was supported in particular by currency translation effects associated with the USD and GBP holdings and by the cash flow from the technical account. Growth was also assisted by the placement of a further subordinated bond with a volume of EUR 500 million. Despite the low interest rate environment, ordinary investment income excluding interest on funds withheld and contract deposits came in modestly higher than the level of the comparable period at EUR 791.8 million (EUR 781.1 million). A positive factor here was stronger income from private equity and real estate investments, which more than offset the diminished returns from fixed-income instruments. Interest on funds withheld and contract deposits amounted to EUR 285.3 million (EUR 267.6 million). Net realised gains increased to EUR 137.4 million (EUR 97.4 million) as at 30 September 2014. Changes in the fair values of financial assets measured at fair value through profit or loss - the so-called ModCo derivatives and the inflation swaps are included here - amounted to EUR -8.8 million (EUR -18.8 million). Investment income from assets under own management climbed by a very pleasing 6.4% as at 30 September 2014 to EUR 836.0 million (EUR 785.6 million). The resulting annualised return on investment amounted to 3.3%. Net investment income including interest on funds withheld and contract deposits improved by 6.5% to EUR 1,121.3 million (EUR 1,053.2 million). Further growth in shareholders' equity Hannover Re's shareholders' equity climbed to a new record high of EUR 7.0 billion as at 30 September 2014 (31 December 2013: EUR 5.9 billion). Despite this increase the annualised return on equity stood at a pleasing 14.4% (31 December 2013: 15.0%). The book value per share reached EUR 58.01 (31 December 2013: EUR 48.83). Outlook 2014 In view of its results for the first nine months, Hannover Re is confident of achieving its full-year targets for 2014. Based on constant exchange rates, the company continues to expect stable to slightly higher gross premium and Group net income after tax in the order of EUR 850 million for the full 2014 financial year. This is conditional on major loss expenditure not significantly exceeding the anticipated level of EUR 670 million and assumes that there are no unforeseen adverse developments on capital markets. In property and casualty reinsurance there are no indications as yet of a change in the market. Nevertheless, reinsurance rates should - aside from certain exceptions - stabilise as at 1 January 2015, since the scope for further reductions is limited in light of the return on equity targets that reinsurers need to meet. Faced with the prevailing soft market, Hannover Re remains committed solely to preserving the profitability and quality of its portfolio in property and casualty reinsurance. The improved performance in life and health reinsurance should be sustained. The full 2014 financial year is therefore expected to close with a significantly stronger result than the previous year. Hannover Re's targeted full-year return on investment is 3.2%. The company is not currently planning to make any significant adjustments to the allocation of its investments to individual asset classes. The focus is primarily on stability while maintaining an adequate risk/return profile. As for the dividend, the company envisages a payout ratio in the range of 35% to 40% of its IFRS Group net income after tax. Outlook 2015 For the 2015 financial year Hannover Re anticipates - adjusted for currency translation effects - stable or slightly higher gross premium. The return on investment will likely be around 3.0%, while Group net income after tax should be in the order of EUR 875 million. As usual, all statements are subject to the proviso that major losses remain within the expected bounds and that there are no unforeseen adverse movements on capital markets. For further information please contact: Corporate Communications: Karl Steinle (tel. +49 511 5604-1500, e-mail: karl.steinle@hannover-re.com) Media Relations: Gabriele Handrick (tel. +49 511 5604-1502, e-mail: gabriele.handrick@hannover-re.com) Investor Relations: Julia Hartmann (tel. +49 511 5604-1529, e-mail: julia.hartmann@hannover-re.com) Please visit: www.hannover-re.com Hannover Re, with gross premium of EUR 14.0 billion, is the third-largest reinsurer in the world. It transacts all lines of property/casualty and life/health reinsurance and is present on all continents with around 2,400 staff. The rating agencies most relevant to the insurance industry have awarded Hannover Re very strong insurer financial strength ratings (Standard & Poor's AA- "Very Strong" and A.M. Best A+ "Superior"). Please note the disclaimer: www.hannover-re.com/misc/disclaimer-pr-050811 <pre> Key figures of the Hannover Re Group (IFRS basis) +/- previous Q1-3/ in EUR million Q1-3/2014 year 2013(1) 2013 Hannover Re Group Gross written premium 10,704.5 +1.6% 10,537.9 Net premium earned 8,966.1 (1.7%) 9,117.3 Net underwriting result (11.8) (51.8%) (24.6) Net investment income 1,121.3 +6.5% 1,053.2 Operating profit (EBIT) 1,090.8 +10.7% 985.8 Group net income 695.4 +10.3% 630.2 Earnings per share in EUR 5.77 +10.3% 5.23 Retention 87.0% 88.9% Tax ratio 25.5% 25.2% EBIT margin(2) 12.2% 10.8% Return on equity 14.4% 14.3% +/- previous in EUR million Q1-3/2014 year Q1-3/2013 2013 Policyholders' surplus 9,635.0 +9.9% 8,767.9 Investments (excl. funds held by ceding companies) 35,033.0 +9.9% 31,875.2 Total assets 59,107.6 +9.6% 53,915.5 Book value per share in EUR 58.01 +18.8% 48.83 Property & Casualty reinsurance in EUR million Q1-3/2014 +/- previous year Q1-3/2013 2013 Gross written premium 6,060.0 +1.7% 5,956.4 Net premium earned 5,104.5 +0.2% 5,093.2 Net underwriting result 225.3 (7.5%) 243.4 Operating profit (EBIT) 846.8 +5.2% 804.6 Group net income 560.8 +5.0% 534.4 Retention 89.6% 89.1% Combined Ratio(3) 95.3% 95.0% EBIT margin(2) 16.6% 15.8% Life & Health reinsurance in EUR million Q1-3/2014 +/- previous year Q1-3/2013(1) 2013 Gross written premium 4,644.6 +1.4% 4,581.6 Net premium earned 3,861.4 (4.0%) 4,023.7 Operating profit (EBIT) 233.9 +39.6% 167.6 Group net income 166.2 +8.6% 153.0 Retention 83.7% 88.5% EBIT margin(2) 6.1% 4.2% </pre> (1) Adjusted on the basis of IAS 8 (2) Operating result (EBIT)/net premium earned (3) Including funds withheld Key figures of the Hannover Re Group (IFRS basis) in EUR million Q3/2014 +/- previous year Q3/2013(1) Hannover Re Group Gross written premium 3,639.6 +9.9% 3,311.2 Net premium earned 3,126.8 +6.9% 2,925.8 Net underwriting result (26.3) (36.4%) (41.4) Net investment income 413.8 +13.6% 364.2 Operating profit (EBIT) 407.1 +39.1% 292.7 Group net income 251.0 +21.4% 206.7 Earnings per share in EUR 2.08 +21.4% 1.71 Retention 85.7% 86.4% Tax ratio 27.1% 20.1% EBIT margin(2) 13.0% 10.0% Return on equity 15.0% 14.6% Property & Casualty reinsurance in EUR million Q3/2014 +/- previous year Q3/2013 Gross written premium 1,981.9 +6.6% 1,859.4 Net premium earned 1,734.2 +2.7% 1,689.3 Net underwriting result 66.9 +11.8% 59.9 Operating profit (EBIT) 325.8 +27.5% 255.5 Group net income 212.9 +23.6% 172.3 Retention 86.6% 86.7% Combined Ratio(3) 95.8% 96.3% EBIT margin(2) 18.8% 15.1% Life & Health reinsurance in EUR million Q3/2014 +/- previous year Q3/2013(1) Gross written premium 1,657.7 +14.2% 1,451.9 Net premium earned 1,392.4 +12.6% 1,236.3 Operating profit (EBIT) 79.1 +134.2% 33.8 Group net income 50.8 (4.9%) 53.4 Retention 84.7% 86.1% EBIT margin(2) 5.7% 2.7% </pre> (1) Adjusted on the basis of IAS 8 (2) Operating result (EBIT)/net premium earned (3) Including funds withheld --------------------------------------------------------------------- 05.11.2014 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------- Language: English Company: Hannover Rück SE Karl-Wiechert-Allee 50 30625 Hannover Germany Phone: +49-(0)511-5604-1500 Fax: +49-(0)511-5604-1648 E-mail: info@hannover-re.com Internet: www.hannover-re.com ISIN: DE0008402215 WKN: 840 221 Indices: MDAX Listed: Regulierter Markt in Frankfurt (Prime Standard), Hannover; Freiverkehr in Berlin, Düsseldorf, Hamburg, München, Stuttgart; Terminbörse EUREX End of News DGAP News-Service --------------------------------------------------------------------- 294985 05.11.2014

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Thanksgiving Dog Safety Is a Pet Care Reality Check

Updated Category News Views 0

A crowded Thanksgiving kitchen can turn a well-behaved dog into a scavenger with lousy odds. Camp Bow Wow’s holiday guidance is not pretending the meal itself is the problem; the trouble is that a house full of distracted people, rich food and unsecured trash creates a pile of easy mistakes. For pet owners, that is a fair reminder. For anybody watching the pet-care...

Continue Reading
Peptide Labels Cannot Substitute for Clinical Care

Updated Category News Views 9

A Label Is Not a Care Plan Those three little words, research use only, carry far more weight than a flashy product page would have people believe. The HelloNation article featuring wellness expert Andres Giraldo makes a plain but necessary distinction: a research-use-only, or RUO, label does not turn a peptide into prescribed treatment, and it sure does not establish...

Continue Reading
Washington-to-Asia Advisory Deal Targets Policy Risk

Updated Category News Views 0

Policy bottlenecks are becoming a cost center across Southeast Asia. That is the plain-English backdrop for the strategic partnership announced November 18, 2026, by Beacon Global Strategies and Vriens & Partners. Neither firm is selling a factory, a chip design, or a new energy project. They are selling something companies increasingly cannot afford to improvise: a...

Continue Reading
Spruce Spins Adrenyx En Route to Nasdaq in 2027

Updated Category News Views 206

New Frontiers: Adrenyx Biosciences Takes Shape Well, here's a new chapter in biotech drama. Spruce Biosciences, a name you might have tangled with if you're into tickers like NASDAQ:SPRB, just carved out a niche with the birth of Adrenyx Biosciences. The play? A separate company eyeing the endocrinology space, setting its sights on tackling congenital adrenal hyperplasia...

Continue Reading
Tactical Tomahawk Motor Deal Puts Propulsion in Focus

Updated Category News Views 31

A missile program lives or dies on unglamorous hardware, and solid rocket motors are about as unglamorous as it gets until somebody cannot build enough of them. Raytheon has awarded Ursa Major and Avio USA a joint contract to develop solid rocket motors for the U.S. Navy’s Tactical Tomahawk missile program. That is the whole headline, and it matters more than the thin...

Continue Reading
Insider Risk Makes Human Judgment a Security Priority

Updated Category News Views 127

A badge, a password, and a locked gate can all look reassuring right up until the person holding them starts to crack. Signpost Six's new report, The Psychology of Insider Risk, lands on an uncomfortable truth: the most consequential security weakness may not be a system at all. It may be an employee under strain, in conflict, in debt, making a mistake, or being quietly...

Continue Reading
Google Search Data Sharing Faces a Privacy Reality Check

Updated Category News Views 91

Search queries are messy little confessions, and that is exactly why this case deserves more than a bureaucratic shrug. Woodway Assurance's independent assessment says Google's search-query data could be treated as anonymized for sharing under the Digital Markets Act, but only if the European Commission tightens parts of its July 2026 framework. That is not a clean bill...

Continue Reading
Kawneer’s OptiQ Window Wins a Useful Design Signal

Updated Category News Views 49

Three Nods, One Very Practical Product Claim Windows rarely stir much excitement outside an architect’s specification binder, but Kawneer has put together a respectable run with its OptiQ Offset Fixed/Projected Series Window. On November 18, 2026, the architectural aluminum-systems maker said the product had won in the Windows and Doors category at both the 2026...

Continue Reading
A Decade of Giving: Light the World Initiative's Impact

Updated Category News Views 157

The Red Kiosk Revolution It's not every day that a church initiative pops up in global conversations, but here we are—ten years into the Light the World initiative by The Church of Jesus Christ of Latter-day Saints. What's interesting is how these little kiosks, like silent ambassadors, have become a staple in 145 spots this holiday season, spanning continents. Each...

Continue Reading
Anycubic Pushes Toward a Smoother 3D Printing Ecosystem

Updated Category News Views 46

Friction Is the Enemy in Consumer 3D Printing A printer that makes a beautiful object only after three failed attempts is not a consumer product; it is a weekend argument with plastic. That is the useful lens for Anycubic's Formnext 2026 showing in Frankfurt on November 18. The company is not merely rolling out FDM and resin machines at Booth F01 in Hall 12.0. It is...

Continue Reading

Top 5 Most Recently Viewed Articles

Bioretec's Innovative Annual Report Showcases New Progress

Updated Category News Views 188

Bioretec Ltd's Annual Report Overview Bioretec Ltd has recently published its annual report for 2024, offering insights into the company's growth and achievements over the past year. This report showcases the advancements made in biodegradable orthopedic implants, positioning the company at the forefront of innovative healthcare solutions. Company Highlights Bioretec...

Continue Reading
Market Overview: Asia Stocks See Fluctuations Amid Election Fears

Updated Category News Views 251

Market Dynamics in Asia: A Closer Look In recent trading sessions, Asian stocks demonstrated muted movements in response to an absence of compelling trading signals, while Japanese shares experienced a notable decline driven by impending democratic choices. Investors are particularly focused on the Japanese electoral scene, which is expected to significantly influence...

Continue Reading
TScan Therapeutics Secures $52.5 Million Loan to Support Growth

Updated Category News Views 113

TScan Therapeutics Secures $52.5 Million Loan from Silicon Valley Bank WALTHAM, Mass. — TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biotechnology company dedicated to developing innovative therapies for cancer treatment, has announced an exciting milestone. The company has entered into a term loan facility with Silicon Valley Bank (SVB) that offers up to...

Continue Reading
Celebrating Four Years of SpaceX's Starlink Internet Service

Updated Category News Views 385

Four Years of Starlink Connectivity Four years ago, SpaceX, under the visionary leadership of Elon Musk, began its journey in satellite internet services by activating Starlink for its first paying customer. This significant milestone was established on a date that marks the beginning of a transformative era for internet connectivity. Impact of Starlink on Global Internet...

Continue Reading
AllenComm Receives Esteemed Recognition in eLearning Field

Updated Category News Views 167

AllenComm Earns Top Honor for eLearning Localization AllenComm, a prominent player in the realm of innovative learning experiences, has recently been recognized as one of the Top Content Providers for eLearning Localization by a well-regarded industry source. This accolade reflects the company's dedication to delivering high-quality, effective educational solutions that...

Continue Reading